Dimerix Ltd has released a press release.
DXB requests US FDA pre IND meeting - performance milestone
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Dimerix
- Dimerix Receives TGA Special Access Scheme Approval
- Activity Report & Appendix 4C
- SBN to undertake SPP
- SBN: Proposed Investment in OMI
- SBN: New Investments
Later from Dimerix
- ARC Linkage Grant to progress discovery platform
- 10 Patient Milestone Reached. On Track to Report Trial Data.
- Update for NASH Pre-Clinical Program
- Outcomes of DMX-200 pre-IND meeting with the FDA
- Response to ASX Price and Volume Query
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix